Anti-Ulcer Agents
-
Subject Areas on Research
- A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution.
- A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.
- Advances in drug therapy for peptic ulcer disease.
- An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia.
- Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
- Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridines.
- Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1,2-a]pyridines and analogues.
- Antiulcer agents. 4. Conformational considerations and the antiulcer activity of substituted imidazo[1,2-a]pyridines and related analogues.
- Attenuation of acid induced oesophagitis in VR-1 deficient mice.
- Bariatric Embolization: Pilot Study on the Impact of Gastroprotective Agents and Arterial Distribution on Ulceration Risk and Efficacy in a Porcine Model.
- Follow-up care after a diagnosis of Helicobacter pylori infection in an Asian immigrant cohort.
- Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners.
- Geranyl-geranyl acetone: a novel stimulant of secretin release in the dog.
- Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
- Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
- Nonsteroidal antiinflammatory drug use among patients with GI bleeding.
- Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
- PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.
- Pediatrician approach to dysphonia.
- Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study.